These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


369 related items for PubMed ID: 21070475

  • 1. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
    Paudyal B, Paudyal P, Oriuchi N, Hanaoka H, Tominaga H, Endo K.
    Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
    [Abstract] [Full Text] [Related]

  • 2. In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.
    Nagengast WB, de Vries EG, Hospers GA, Mulder NH, de Jong JR, Hollema H, Brouwers AH, van Dongen GA, Perk LR, Lub-de Hooge MN.
    J Nucl Med; 2007 Aug; 48(8):1313-9. PubMed ID: 17631557
    [Abstract] [Full Text] [Related]

  • 3. Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with Cu-labeled trastuzumab PET.
    Paudyal P, Paudyal B, Hanaoka H, Oriuchi N, Iida Y, Yoshioka H, Tominaga H, Watanabe S, Watanabe S, Ishioka NS, Endo K.
    Cancer Sci; 2010 Apr; 101(4):1045-50. PubMed ID: 20219072
    [Abstract] [Full Text] [Related]

  • 4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [Abstract] [Full Text] [Related]

  • 5. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.
    Li F, Jiang S, Zu Y, Lee DY, Li Z.
    J Nucl Med; 2014 Sep; 55(9):1525-31. PubMed ID: 24970912
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography.
    Achmad A, Hanaoka H, Yoshioka H, Yamamoto S, Tominaga H, Araki T, Ohshima Y, Oriuchi N, Endo K.
    Cancer Sci; 2012 Mar; 103(3):600-5. PubMed ID: 22126621
    [Abstract] [Full Text] [Related]

  • 12. Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies.
    Heskamp S, Boerman OC, Molkenboer-Kuenen JD, Oyen WJ, van der Graaf WT, van Laarhoven HW.
    Int J Cancer; 2013 Jul 15; 133(2):307-14. PubMed ID: 23335047
    [Abstract] [Full Text] [Related]

  • 13. Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor.
    Marquez BV, Ikotun OF, Parry JJ, Rogers BE, Meares CF, Lapi SE.
    J Nucl Med; 2014 Jun 15; 55(6):1029-34. PubMed ID: 24732153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody.
    Stollman TH, Scheer MG, Leenders WP, Verrijp KC, Soede AC, Oyen WJ, Ruers TJ, Boerman OC.
    Int J Cancer; 2008 May 15; 122(10):2310-4. PubMed ID: 18240146
    [Abstract] [Full Text] [Related]

  • 18. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.
    Persson M, El Ali HH, Binderup T, Pfeifer A, Madsen J, Rasmussen P, Kjaer A.
    Nucl Med Biol; 2014 Mar 15; 41(3):290-5. PubMed ID: 24533988
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature.
    Chen K, Sun X, Niu G, Ma Y, Yap LP, Hui X, Wu K, Fan D, Conti PS, Chen X.
    Mol Imaging Biol; 2012 Feb 15; 14(1):96-105. PubMed ID: 21360213
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
    Chen K, Ma W, Li G, Wang J, Yang W, Yap LP, Hughes LD, Park R, Conti PS.
    Mol Pharm; 2013 Jan 07; 10(1):417-27. PubMed ID: 23190134
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.